B. Camisa

发表

Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease.

S. Ferrari, C. Brignole, M. Ponzoni, 2009, The American journal of pathology.

Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene

C. Bordignon, A. Stornaiuolo, F. Ciceri, 2018, Front. Immunol..

Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients

F. Ciceri, B. Camisa, C. Bonini, 2020, Frontiers in Immunology.

Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.

C. Bordignon, M. Ponzoni, C. Tresoldi, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism

M. Roncarolo, A. Lombardo, F. Ciceri, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Modeling Human Graft-Versus-Host Disease in Immunocompromised Mice.

B. Camisa, A. Bondanza, M. Norelli, 2016, Methods in molecular biology.

Inter-species differences in sensitivity to the calcemic activity of the novel 1,25-dihydroxyvitamin D3 analog BXL746.

B. Camisa, D. d'Ambrosio, Enrico Baroni, 2008, Regulatory toxicology and pharmacology : RTP.

CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome

F. Sanvito, M. Ponzoni, F. Ciceri, 2022, The Journal of clinical investigation.

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

C. Doglioni, M. Genua, C. Bordignon, 2018, Nature Medicine.

Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies

C. Doglioni, A. Graziani, E. Angelino, 2022, Science Translational Medicine.

IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

S. Bicciato, M. Forcato, F. Cocchiarella, 2013, Blood.

Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans

A. N. Davydov, Shannon K. Boi, C. Peano, 2020, Nature Immunology.

Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans

A. N. Davydov, Shannon K. Boi, C. Peano, 2020, Nature immunology.

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

A. Annoni, C. Brombin, L. Naldini, 2018, Nature Communications.

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

C. Doglioni, M. Genua, C. Bordignon, 2018, Nature Medicine.

CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma.

L. Naldini, M. Marcatti, C. Bordignon, 2013, Blood.

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

Lei Zhang, Luigi Naldini, Giulia Casorati, 2012, Nature Medicine.

Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.

G. Linette, C. June, F. Sanvito, 2022, Cancer cell.

The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer

M. Falconi, M. Bianchi, C. Doglioni, 2019, Journal of Immunotherapy for Cancer.

The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.

P. Viganò, M. Candiani, D. Gentilini, 2012, Human reproduction.

from naive precursors IL-7 and IL-15 instruct the generation of human memory stem T cells

S. Bicciato, M. Forcato, F. Cocchiarella, 2013 .

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.

L. Naldini, A. Reik, M. Holmes, 2017, Blood.

Title : NY-ESO-1 TCR single edited central memory and memory stem T cells to treat multiple myeloma without inducing GvHD

L. Naldini, A. Reik, M. Holmes, 2017 .

Co-Expression of a Suicide Gene in CAR-Redirected T Cells Enables the Safe Targeting of CD44v6 for Leukemia and Myeloma Eradication

L. Naldini, C. Bordignon, F. Ciceri, 2012 .

CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses

F. Ciceri, B. Camisa, C. Bonini, 2023, Journal for ImmunoTherapy of Cancer.

CD 44 v 6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

L. Naldini, M. Marcatti, C. Bordignon, 2013 .

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function

R. Galli, M. Genua, M. Arredouani, 2022, Science Translational Medicine.

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells

G. Tonon, D. Lazarević, C. Doglioni, 2023, Gut.

The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.

P. Viganò, M. Candiani, D. Gentilini, 2012, Human reproduction.

Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus

B. Camisa, M. Casucci, R. Norata, 2024, Nature communications.

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells

Eric Shifrut, B. Camisa, Z. Magnani, 2024, Frontiers in immunology.